{"name":"Benova (Tianjin) Innovative medicine Research Co., Ltd.","slug":"benova-tianjin-innovative-medicine-research-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Fosfomycin Tromethamine Granules","genericName":"Fosfomycin Tromethamine Granules","slug":"fosfomycin-tromethamine-granules","indication":"Uncomplicated urinary tract infections (acute cystitis)","status":"phase_3"},{"name":"Pivmecillinam hydrochloride tablets","genericName":"Pivmecillinam hydrochloride tablets","slug":"pivmecillinam-hydrochloride-tablets","indication":"Urinary tract infections","status":"phase_3"}]}],"pipeline":[{"name":"Fosfomycin Tromethamine Granules","genericName":"Fosfomycin Tromethamine Granules","slug":"fosfomycin-tromethamine-granules","phase":"phase_3","mechanism":"Fosfomycin inhibits bacterial cell wall synthesis by inactivating the enzyme enolpyruvate transferase, preventing peptidoglycan cross-linking.","indications":["Uncomplicated urinary tract infections (acute cystitis)","Bacterial infections susceptible to fosfomycin"],"catalyst":""},{"name":"Pivmecillinam hydrochloride tablets","genericName":"Pivmecillinam hydrochloride tablets","slug":"pivmecillinam-hydrochloride-tablets","phase":"phase_3","mechanism":"Pivmecillinam hydrochloride is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis.","indications":["Urinary tract infections"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}